This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Tranexamic Acid

Read time: 1 mins
Marketing start date: 23 Nov 2024
...
 

Summary of product characteristics


Effective Time

20221105

Version

5

Spl Product Data Elements

Tranexamic Acid Tranexamic Acid TRANEXAMIC ACID TRANEXAMIC ACID WATER

Application Number

ANDA205228

Brand Name

Tranexamic Acid

Generic Name

Tranexamic Acid

Product Ndc

70771-1085

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAVENOUS

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL CONTAINER LABEL NDC 70771-1085-1 Tranexamic Acid Injection 1000 mg/10 mL (100 mg/mL) Solution for Intravenous Injection Discard any remaining portion after single use. 10 mL Single-Dose Vial Rx only zydus pharmaceuticals CARTON LABEL NDC 70771-1085-6 Tranexamic Acid Injection 1000 mg/10 mL (100 mg/mL) Solution for Intravenous Injection Discard any remaining portion after single use. 10 X 10 mL Single-Dose Vials Rx only zydus pharmaceuticals figure02 figure03

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.